Zacks Investment Management’s Vaxcyte PCVX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$463K	Buy	14,250 +371	+3%	+$12.1K	﹤0.01%	493
2025 Q1	$524K	Buy	13,879 +1,685	+14%	+$63.6K	﹤0.01%	470
2024 Q4	$998K	Sell	12,194 -1,451	-11%	-$119K	0.01%	423
2024 Q3	$1.56M	Buy	+13,645	New	+$1.56M	0.01%	373